Credit Suisse’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $519K | Buy |
65,357
+3,595
| +6% | +$28.5K | ﹤0.01% | 2621 |
|
|
2023
Q4 | $611K | Sell |
61,762
-981
| -2% | -$9.71K | ﹤0.01% | 2621 |
|
|
2023
Q3 | $706K | Buy |
62,743
+10,176
| +19% | +$115K | ﹤0.01% | 2486 |
|
|
2023
Q2 | $175K | Sell |
52,567
-1,277
| -2% | -$4.24K | ﹤0.01% | 3094 |
|
|
2023
Q1 | $213K | Buy |
53,844
+2,472
| +5% | +$9.76K | ﹤0.01% | 3081 |
|
|
2022
Q4 | $372K | Buy |
51,372
+23,593
| +85% | +$171K | ﹤0.01% | 2919 |
|
|
2022
Q3 | $100K | Buy |
27,779
+234
| +0.8% | +$842 | ﹤0.01% | 3411 |
|
|
2022
Q2 | $125K | Buy |
27,545
+2,361
| +9% | +$10.7K | ﹤0.01% | 3466 |
|
|
2022
Q1 | $191K | Buy |
25,184
+1,762
| +8% | +$13.4K | ﹤0.01% | 3369 |
|
|
2021
Q4 | $256K | Buy |
+23,422
| New | +$256K | ﹤0.01% | 3359 |
|